In our cohort of patients with grade II–III obesity undergoing evaluation for bariatric surgery, MASLD prevalence was higher (85.8%), with lower MASL prevalence (36.9%) and higher prevalence of MASH (48.9%) and fibrosis (26%). Here, MAS1L is linked to Obesity.